Mignogna, Michele Davide <br/><br/>
Adjuvant high-dose intravenous immunoglobulin therapy can be easily and safely introduced as an alternative treatment in patients with severe pemphigus vulgaris: a retrospective preliminary study.  [electronic resource] 

 -  American journal of clinical dermatology  2008 
 - 323-31 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1175-0561 
<br/><br/><label>Standard No.: </label>10.2165/00128071-200809050-00007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Female<br/>Humans<br/>Immunoglobulins, Intravenous--therapeutic use<br/>Male<br/>Middle Aged<br/>Pemphigus--drug therapy<br/>Retrospective Studies<br/>Statistics, Nonparametric<br/>Treatment Outcome